节点文献

新型重组免疫抑制融合毒素蛋白B7-2-PE40KDEL的分离纯化

Establishment of Purification Procedure for Recombinant Fusion Protein B7-2-PE40KDEL

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 关海容孙玉英袁志宏张惠丽梁飞刘楠郭斯启习彩霞奚永志

【Author】 GUAN Hai-Rong, SUN Yu-Ying, YUAN Zhi-Hong, ZHANG Hui-Li, LIANG Fei, LIU Nan, GUO Si-Qi, XI Cai-Xia, XI Yong-ZhiDepartment of Immunology, Hospital Affiliated to Academy of Military Medical Sciences; Laboratory of Immunoassay, National Center of Biomedical Analysis, Beijing 100071, China

【机构】 军事医学科学院附属医院免疫学研究室及国家生物医学分析中心免疫学研究室军事医学科学院附属医院免疫学研究室及国家生物医学分析中心免疫学研究室 100071100071

【摘要】 为了建立高效快捷能分离大量重组B7-2-PE40KDEL融合蛋白的下游纯化路线,比较了不同组合的纯化策略和条件,包括反相层析、金属螯合层析、阴离子交换层析、蓝染料亲和层析和凝胶过滤层析等,并采用MTT法检测该融合蛋白的靶向杀伤活性。结果表明,在反相层析分离中疏水相分别采用了常规的甲醇和乙腈,结果为所分离的该重组融合蛋白均发生了变性,从色谱柱中分离出来就生成了絮状沉淀。在蓝染料亲和层析一步分离中,由于全菌体蛋白中与亲和树脂发生非特异结合的成分较多,极难区分目的蛋白和杂蛋白。但是,PRSETA-B7-2-PE40KDEL表达载体上带有翻译增强序列T7-g10,可在表达目的蛋白N端融合6个组氨酸,这十分有利于通过Ni-NTA金属鏊和层析法快速高纯度地纯化表达产物。根据这一特性,经反复筛选实验设计最终确定了金属螯合层析、阴离子交换层析和凝胶过滤层析三步法的纯化路线,用于纯化分离B7-2-PE40KDEL融合蛋白。所得的目的蛋白的纯度可达95%以上,总回收率为8%。Western-blot实验显示,所得蛋白可与B7-2及PEA抗体特异性结合;MTT生物活性测定表明,该融合蛋白对表达CD28受体的人T细胞系Jurkat产生特异性杀伤作用,而对不表达CD28的淋巴细胞系Raji无任何杀伤作用。结论:建立了高效快速纯化大量重组B7-2-PE40KDEL融合蛋白的技术路线,所纯化的重组B7-2-PE40KDEL融合蛋白能特异性靶向杀伤表达CD28受体的人T细胞。

【Abstract】 This study was aimed to establish downstream purification procedure by which the protein of interest can be purified to higher purity rapidly and efficiently. The different combinations of various purification strategies, methods and conditions were compared, including reversed phase chromatography, metal chelating chromatography, anion exchange chromatography, blue dye affinity chromatography, filtration chromatography and so on. The results showed that in reversed phase chromatography, isolated protein of interest was denatured and precipitated immediately after chromatography because methanol or acetonitrile were adopted as the organic phase. In blue dye affinity chromatography expecting to purify the protein of interest in one step, protein of interest was difficultly differentiated from mixed protein as much proteins bound to the chromatography media by non-specific affinity. While there is a translation-enhancing sequence T7-g10 in the PRSETA-B7-2-PE40KDEL expression vector, so it adds 6 histidines to the N terminus of the protein of interest, this allows to purify the protein of interest by metal chelating chromatography. Based on this characteristic, a three-step chromatography line including metal chelating chromatography, anion exchange chromatography and filtration chromatography was finally established after repeated experiments. By this way the purity of protein of interest reached 95% and the total recovery rate was 8%. The result of Western blot indicated that the expressed and purified recombinant B7-2-PE40KDEL could specifically bind with mAb against human B7-2 and multiple antibody against PEA. The cytotoxicity of the recombinant toxin tested by MTT method showed that the B7-2-PE40KDEL could selectively kill Jurkat cell line expressing CD28 receptor well and had no killing effect on the Raji cell line unexpresing CD28 receptor. It is concluded that a high efficient and speedy three-step purification procedure for the purifing recombinant protein B7-2-PE40KDEL was established, and this procedure possess selective killing activity on CD28 positive T lymphocytes.

【基金】 国家自然科学基金资助课题,编号30200111
  • 【文献出处】 中国实验血液学杂志 ,Journal of Experimental Hematology , 编辑部邮箱 ,2006年01期
  • 【分类号】Q78
  • 【被引频次】3
  • 【下载频次】145
节点文献中: 

本文链接的文献网络图示:

本文的引文网络